Peripheral T Cell Determinants of Response and Resistance to Pembrolizumab in Melanoma
University of California, San Francisco
University of California, San Francisco
Wake Forest University Health Sciences
Mayo Clinic
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
City of Hope Medical Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Washington University School of Medicine
National Cancer Institute (NCI)
Children's Oncology Group
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Wake Forest University Health Sciences
National Cancer Institute (NCI)
University of Nebraska
Duke University
Mayo Clinic
Dana-Farber Cancer Institute
National Cancer Institute (NCI)
I.M. Sechenov First Moscow State Medical University
Inova Health Care Services
Fox Chase Cancer Center
University of Chicago
University of Puerto Rico
Mayo Clinic
Abramson Cancer Center at Penn Medicine
Case Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
University of Washington
The Oxford Dental College, Hospital and Research Center, Bangalore, India
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Memorial Sloan Kettering Cancer Center
AdventHealth
Roswell Park Cancer Institute
University of Pittsburgh
M.D. Anderson Cancer Center
Groupe Oncologie Radiotherapie Tete et Cou
OHSU Knight Cancer Institute
Alliance for Clinical Trials in Oncology